Diversified Healthcare Trust (NASDAQ:DHC) went up by 2.25% from its latest closing price compared to the recent 1-year high of $5.58. The company’s stock price has collected 6.12% of gains in the last five trading sessions. Press Release reported on 10/06/21 that Diversified Healthcare Trust Third Quarter 2021 Conference Call Scheduled for Thursday, November 4(th)
Is It Worth Investing in Diversified Healthcare Trust (NASDAQ :DHC) Right Now?
Plus, the 36-month beta value for DHC is at 1.38. Opinions of the stock are interesting as 1 analysts out of 5 who provided ratings for Diversified Healthcare Trust declared the stock was a “buy,” while 0 rated the stock as “overweight,” 2 rated it as “hold,” and 1 as “sell.”
The average price from analysts is $4.56, which is $0.86 above the current price. DHC currently public float of 235.10M and currently shorts hold a 3.04% ratio of that float. Today, the average trading volume of DHC was 1.08M shares.
DHC’s Market Performance
DHC stocks went up by 6.12% for the week, with a monthly jump of 5.81% and a quarterly performance of -12.50%, while its annual performance rate touched -0.14%. The volatility ratio for the week stands at 2.70% while the volatility levels for the past 30 days are set at 3.40% for Diversified Healthcare Trust. The simple moving average for the period of the last 20 days is 4.69% for DHC stocks with a simple moving average of -11.94% for the last 200 days.
Analysts’ Opinion of DHC
Many brokerage firms have already submitted their reports for DHC stocks, with Wells Fargo repeating the rating for DHC by listing it as a “Underweight.” The predicted price for DHC in the upcoming period, according to Wells Fargo is $4 based on the research report published on December 10th of the previous year 2020.
Wells Fargo gave a rating of “Equal Weight” to DHC, setting the target price at $9 in the report published on January 17th of the previous year.
DHC Trading at 0.76% from the 50-Day Moving Average
After a stumble in the market that brought DHC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -34.77% of loss for the given period.
Volatility was left at 3.40%, however, over the last 30 days, the volatility rate increased by 2.70%, as shares surge +6.74% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -5.21% lower at present.
During the last 5 trading sessions, DHC rose by +6.12%, which changed the moving average for the period of 200-days by -14.15% in comparison to the 20-day moving average, which settled at $3.49. In addition, Diversified Healthcare Trust saw -11.65% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at DHC starting from HARRINGTON JOHN L., who sale 19,500 shares at the price of $3.62 back on May 12. After this action, HARRINGTON JOHN L. now owns 0 shares of Diversified Healthcare Trust, valued at $70,530 using the latest closing price.
HARRINGTON JOHN L., the Director of Diversified Healthcare Trust, sale 26,500 shares at $3.90 during a trade that took place back on May 07, which means that HARRINGTON JOHN L. is holding 19,500 shares at $103,382 based on the most recent closing price.
Stock Fundamentals for DHC
Current profitability levels for the company are sitting at:
- -23.84 for the present operating margin
- -24.06 for the gross margin
The net margin for Diversified Healthcare Trust stands at -11.48. The total capital return value is set at -4.58, while invested capital returns managed to touch -2.40. Equity return is now at value -9.20, with -3.20 for asset returns.
Based on Diversified Healthcare Trust (DHC), the company’s capital structure generated 143.08 points at debt to equity in total, while total debt to capital is 58.86. Total debt to assets is 55.14, with long-term debt to equity ratio resting at 130.93. Finally, the long-term debt to capital ratio is 53.86.
When we switch over and look at the enterprise to sales, we see a ratio of 3.77, with the company’s debt to enterprise value settled at 0.78. The receivables turnover for the company is 1,220.46 and the total asset turnover is 0.18.